Renaissance Technologies’s Neurotrope, Inc. Common NTRP Stock Holding History

Renaissance Technologies’s Portfolio NTRP Stock Details NTRP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-337,538	Closed	-$375K	–	3864
2020 Q3	$375K	Buy	337,538 +93,342	+38%	+$107K	﹤0.01%	2927
2020 Q2	$283K	Buy	244,196 +228,886	+1,495%	+$287K	﹤0.01%	3062
2020 Q1	$13K	Buy	+15,310	New	+$16.7K	﹤0.01%	3382
2019 Q4	–	Sell	-42,433	Closed	-$34K	–	3833
2019 Q3	$34K	Sell	42,433 -96,000	-69%	-$440K	﹤0.01%	3354
2019 Q2	$1.11M	Sell	138,433 -21,014	-13%	-$141K	﹤0.01%	2630
2019 Q1	$869K	Buy	159,447 +84,700	+113%	+$364K	﹤0.01%	2728
2018 Q4	$267K	Buy	74,747 +24,747	+49%	+$150K	﹤0.01%	3063
2018 Q3	$441K	Buy	50,000 +21,000	+72%	+$201K	﹤0.01%	2888
2018 Q2	$281K	Buy	+29,000	New	+$267K	﹤0.01%	2985

Other funds holding NTRP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Renaissance Technologies's NTRP Position: Q4 2020 in Review

Renaissance Technologies sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 337,538 shares — an estimated $375K sold.

Renaissance Technologies first reported a position in NTRP in Q2 2018 and held it in 9 quarters. The position peaked at $1.11M in Q2 2019. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.

Renaissance Technologies reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
Renaissance Technologies sold 337,538 Neurotrope, Inc. Common shares in Q4 2020, an estimated $375K.
Renaissance Technologies first reported a position in Neurotrope, Inc. Common in Q2 2018 and held it in 9 quarters.
Renaissance Technologies's Neurotrope, Inc. Common position peaked at $1.11M in Q2 2019.
1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.

Based on Renaissance Technologies's 13F filing for Q4 2020, filed 10 Feb 2021.